Jul 2026· Journal of environmental biology· Vol 47, pp. 876-883· 0 citations
TL;DR
Multiple genetic loci were identified, reaffirming the contribution of immune dysregulation and impaired skin barrier function in psoriasis and reaffirming the contribution of immune dysregulation and impaired skin barrier function in psoriasis.
Abstract
Aim: To identify and functionally characterise key genetic susceptibility loci for psoriasis using GWAS data integrated with pathway, network, and regulatory analyses.
Methodology: GWAS datasets were systematically analysed to identify genes and genetic variants associated with psoriasis. Functional enrichment analyses were performed to delineate key biological pathways, regulatory elements, and functional annotations. Furthermore, transcription factor and microRNA interactions with psoriasis-related genes were evaluated to provide mechanistic insights.
Results: Multiple genetic loci were identified, reaffirming the contribution of immune dysregulation and impaired skin barrier function in psoriasis. Functional enrichment highlighted significant pathways including cytokine signalling, NF-κB activation, and keratinocyte proliferation. Several transcription factors and miRNAs regulating psoriasis-associated genes were also identified, offering additional layers of gene expression control.
Interpretation: Integration of GWAS findings with pathway and regulatory network analyses enhances the understanding of psoriasis genetics. Novel susceptibility genes, transcriptional regulators, and potential biomarkers have been identified, which may serve as therapeutic targets. Future research should focus on experimental validation and clinical translation to advance precision medicine approaches in psoriasis management.
Key words: Genetic susceptibility, GWAS Psoriasis, Immune-related loci, Inflammatory skin disease, Psoriasis genetics
An integrative multi-omics analysis nominates BLMH as a keratinocyte-enriched protective candidate gene in psoriasis and suggests tamibarotene as a potential repurposed compound for further investigation.
Rui Shen, Bin-Yi Ran, Jia-Zheng Liu et al.· Journal of Inflammation Rese...· 0 citations
Combining multiple genetic, genomic, and functional data is a useful approach for prioritizing the most likely causal gene within IBD GWAS loci, and for prioritizing functional validation studies in epithelial cells and tissues.
I. Hébert-Milette, Virginie Mercier, Jean Paquette et al.· medRxiv· 0 citations
It is demonstrated that genomic susceptibility is organised into biologically distinct profiles defined by coordinated variant, gene, pathway, and cumulative risk signals, which provides a practical basis for risk stratification and supports the application of genomics in personalised medicine.
Bana Sarahbibi Mohmedsalim, Subhabrata Sarkar, Sukanta Bandyopadhyay et al.· Genetics and Molecular Resea...· 0 citations
Rheumatoid arthritis (RA) is an autoimmune disease involving the interaction of genetic and immunological factors. Genome-wide association studies (GWAS) have identified many RA risk loci, but the biological mechanisms linking genetic variation to disease pathogenesis are not yet fully understood. This study aims to pr...
Muhammad Nuh, L. Lolita· International Journal of Pub...· 0 citations
Evidence is provided for a shared, albeit modest, and genetic basis between EMS and IBD that is likely mediated through immune regulation, hormonal signaling, and tissue repair that is likely mediated through immune regulation, hormonal signaling, and tissue repair.
Xinyue Cui, Jian-Hong Wang, Jingjing Chen et al.· BioMed Research Internationa...· 0 citations
Using summary statistics from genome-wide association studies for 37 cancer types, extensive genome-wide and local genetic correlations among cancers are identified and 33 novel functional genes harboring previously unreported cancer risk variants are identified.
Xiao-Hong Wu, Yu-Qing Yan, Wen Cao et al.· Briefings in Bioinformatics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.